清醒微血管减压术治疗三叉神经痛:概念与初步结果
这项前瞻性研究纳入10例连续接受微血管减压术的三叉神经痛成人患者,在清醒麻醉方案下手术,术中评估疼痛以判断减压是否充分。9例手术成功(BNI I级5例、II级4例),1例无疼痛缓解(BNI IV级)并出现假性脑膜膨出;中位随访16.5个月,1例在11个月时复发。作者认为术中清醒测试可能通过快速识别并处理减压不充分而提高手术成功率。
要点
- 10例患者均耐受清醒微血管减压术,术中及术后均无需改全身气管插管麻醉。
- 9例手术成功(BNI I级5例、II级4例),1例无疼痛缓解(BNI IV级)。
- 2例术中清醒测试未见诱发痛缓解,进一步探查发现次要责任血管并减压后疼痛缓解。
核心结论
- 作者认为,术中清醒测试治疗疗效可能通过快速识别并处理三叉神经减压不充分来提高微血管减压术的成功率。
研究设计与样本
- 经机构审查委员会批准的前瞻性研究,连续纳入10例因三叉神经痛接受微血管减压术的成人患者。
- 主要结局指标为术后三叉神经痛疼痛,采用巴罗神经学研究所(BNI)疼痛严重程度量表量化。
主要发现
- 患者中位年龄65.5岁,女性与男性比例为6:4。
- 全部10例患者均良好耐受手术,术中及术后均未需全身气管插管麻醉。
- 9例手术成功(BNI I级5例、II级4例),1例无疼痛缓解(BNI IV级)。
- 该无疼痛缓解患者出现假性脑膜膨出,为本系列唯一的手术并发症。
- 1例在11个月时疼痛复发,BNI评分从I级升至II级;中位随访时间16.5个月。
临床怎么用
- 作者认为,术中清醒测试治疗疗效可能通过快速识别并处理三叉神经减压不充分来提高微血管减压术的成功率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this initial series, we evaluated the use of microvascular decompression (MVD) under an awake anesthesia protocol ("awake" MVD) to assess whether intraoperative pain evaluation can identify and mitigate insufficient decompression of the trigeminal nerve, improving surgical outcomes, and possibly expand the indications of MVD in patients with comorbidities that would preclude the use of general endotracheal anesthesia (GEA). METHODS: An Institutional Review Board-approved prospective study of 10 consecutive adults who underwent MVD for trigeminal neuralgia (TN) was conducted. The primary outcome measure was postoperative TN pain quantified on the Barrow Neurological Institute (BNI) Pain Severity Scale. RESULTS: The median patient age was 65.5 years, with a female:male ratio of 6:4. All 10 patients tolerated the procedure well and did not require GEA intraoperatively or postoperatively. Nine patients had a successful surgical outcome (BNI score I, n = 5; BNI score II, n = 4). One patient did not have pain relief (BNI score IV). This same patient also developed a pseudomeningocele, which was the sole surgical complication observed in this series. One patient experienced recurrence of pain at 11 months, with BNI score increasing from I to II. The median duration of follow-up was 16.5 months. Two patients did not experienced resolution of evoked pain during intraoperative awake testing following decompression. Further intraoperative exploration revealed secondary offending vessels that were subsequently decompressed, leading to resolution of pain. CONCLUSIONS: Intraoperative awake testing for treatment efficacy may increase the success rate of MVD by rapidly identifying and mitigating insufficient cranial nerve V decompression.
引用
- Abdulrauf SI, Urquiaga JF, Patel R, et al. Awake Microvascular Decompression for Trigeminal Neuralgia: Concept and Initial Results. World Neurosurg. 2018. PMID: 29452326. doi:10.1016/j.wneu.2018.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。